Yamaoka, K., Tanaka, Y., Kameda, H., Khan, N., Sasaki, N., Harigai, M., . . . Takeuchi, T. (2021). The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan. Drug Saf.
Chicago-stil citatYamaoka, Kunihiro, Yoshiya Tanaka, Hideto Kameda, Nasser Khan, Nobuhito Sasaki, Masayoshi Harigai, Yanna Song, Ying Zhang, och Tsutomu Takeuchi. "The Safety Profile of Upadacitinib in Patients With Rheumatoid Arthritis in Japan." Drug Saf 2021.
MLA-referensYamaoka, Kunihiro, et al. "The Safety Profile of Upadacitinib in Patients With Rheumatoid Arthritis in Japan." Drug Saf 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.